Cortex Pharmaceuticals, Inc. Appoints Les Street, Ph.D., Head of Medicinal Chemistry and Steven A. Johnson, Ph.D., VP of Pre-Clinical Development Becomes an Officer of Cortex Pharmaceuticals, Inc.

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (AMEX: COR) has named Les Street, Ph.D., Head of Medicinal Chemistry, and Steven A. Johnson, Ph.D., VP of Pre-Clinical Development, has been appointed an Officer of Cortex by the Cortex Board of Directors.